Insider Trading - Cox John

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Cox John

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-02-24
Sale
2020-02-26
4:27 pm
REPLIGEN CORP RGEN Cox John
Director
4,455 $92.81 $413,455 2,781
(Direct)
View
2020-03-04
Sale
2020-03-05
5:52 pm
REPLIGEN CORP RGEN Cox John
Director
10,000 $93.39 $933,900 2,781
(Direct)
View
2020-03-18
Sale
2020-03-20
4:25 pm
REPLIGEN CORP RGEN Cox John
Director
26,736 $95.27 $2,547,035 2,781
(Direct)
View
2020-03-24
Sale
2020-03-26
7:31 pm
REPLIGEN CORP RGEN Cox John
Director
1,858 $96.72 $179,706 923
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-02-14
Option Award
2017-02-16
4:38 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
73,017 $0 73,017
(Direct)
View
2017-02-14
Option Award
2017-02-16
4:38 pm
N/A
2027-02-14
Bioverativ Inc. BIVV Cox John
CEO
193,337 $0 193,337
(Direct)
View
2017-02-14
Option Award
2017-02-16
4:38 pm
N/A
2027-02-14
Bioverativ Inc. BIVV Cox John
CEO
386,675 $0 386,675
(Direct)
View
2017-02-28
Option Award
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
211,679 $0 226,979
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
3,404 $43.42 223,575
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
3,383 $49.56 220,192
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
8,355 $47.76 211,837
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
6,986 $43.42 204,851
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
2,641 $49.56 202,210
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
6,436 $47.76 195,774
(Direct)
View
2017-02-28
Tax Withholding
2017-03-02
4:08 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
6,726 $43.42 189,048
(Direct)
View
2017-02-28
Option Award
2017-03-02
4:08 pm
N/A
2019-02-23
Bioverativ Inc. BIVV Cox John
CEO
48,230 $0 48,230
(Direct)
View
2017-02-28
Option Award
2017-03-02
4:08 pm
N/A
2018-02-11
Bioverativ Inc. BIVV Cox John
CEO
18,381 $0 18,381
(Direct)
View
2017-02-14
Option Award
2017-03-27
4:27 pm
N/A
2027-02-14
Bioverativ Inc. BIVV Cox John
CEO
193,683 $0 193,683
(Direct)
View
2017-02-14
Option Award
2017-03-27
4:27 pm
N/A
2027-02-14
Bioverativ Inc. BIVV Cox John
CEO
387,366 $0 387,366
(Direct)
View
2017-03-31
Tax Withholding
2017-04-03
4:16 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
8,416 $54.46 180,632
(Direct)
View
2017-05-18
Option Award
2017-05-22
5:01 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
1,206 $0 4,827
(Direct)
View
2017-05-18
Option Award
2017-05-22
5:01 pm
2018-05-18
2027-05-18
REPLIGEN CORP RGEN Cox John
Director
2,434 $0 2,434
(Direct)
View
2018-01-31
Option Award
2018-02-02
5:07 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
136,364 $0 136,364
(Direct)
View
2018-02-11
Exercise
2018-02-13
5:01 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
18,381 $9.53 199,013
(Direct)
View
2018-02-11
Tax Withholding
2018-02-13
5:01 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
7,672 $103.05 191,341
(Direct)
View
2018-02-11
Exercise
2018-02-13
5:01 pm
N/A
2018-02-11
Bioverativ Inc. BIVV Cox John
CEO
18,381 $0 0
(Direct)
View
2018-02-14
Exercise
2018-02-15
5:04 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
24,339 $0 215,680
(Direct)
View
2018-02-14
Tax Withholding
2018-02-15
5:04 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
10,819 $103.52 204,861
(Direct)
View
2018-02-14
Exercise
2018-02-15
5:04 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
24,339 $0 48,678
(Direct)
View
2018-02-22
Tax Withholding
2018-02-26
5:11 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
13,973 $104.3 190,888
(Direct)
View
2018-02-22
Tax Withholding
2018-02-26
5:11 pm
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
5,794 $104.74 185,094
(Direct)
View
2018-03-08
Disposition
2018-03-08
11:47 am
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
185,094 $0 0
(Direct)
View
2018-03-08
Disposition
2018-03-08
11:47 am
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
136,364 $0 0
(Direct)
View
2018-03-08
Disposition
2018-03-08
11:47 am
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
48,678 $0 0
(Direct)
View
2018-03-08
Disposition
2018-03-08
11:47 am
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
48,230 $0 0
(Direct)
View
2018-03-08
Disposition
2018-03-08
11:47 am
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
387,366 $0 0
(Direct)
View
2018-03-08
Disposition
2018-03-08
11:47 am
N/A
N/A
Bioverativ Inc. BIVV Cox John
CEO
193,683 $0 0
(Direct)
View
2018-05-16
Option Award
2018-05-17
4:43 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
1,486 $0 6,313
(Direct)
View
2018-05-16
Option Award
2018-05-17
4:43 pm
2019-05-16
2028-05-16
REPLIGEN CORP RGEN Cox John
Director
3,304 $0 3,304
(Direct)
View
2019-05-15
Option Award
2019-05-17
4:11 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
923 $0 7,236
(Direct)
View
2019-05-15
Option Award
2019-05-17
4:11 pm
2020-05-15
2029-05-15
REPLIGEN CORP RGEN Cox John
Director
2,109 $0 2,109
(Direct)
View
2020-03-04
Exercise
2020-03-05
5:52 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
10,000 $12.91 12,781
(Direct)
View
2020-03-04
Exercise
2020-03-05
5:52 pm
N/A
2023-11-15
REPLIGEN CORP RGEN Cox John
Director
10,000 $0 14,000
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
14,000 $12.91 16,781
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
3,632 $41.19 20,413
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
3,366 $26.12 23,779
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
2,434 $38.76 26,213
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORP RGEN Cox John
Director
3,304 $42.07 29,517
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
2023-11-15
REPLIGEN CORP RGEN Cox John
Director
14,000 $0 0
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
2025-05-21
REPLIGEN CORP RGEN Cox John
Director
3,632 $0 0
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
2026-05-11
REPLIGEN CORP RGEN Cox John
Director
3,366 $0 0
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
2027-05-18
REPLIGEN CORP RGEN Cox John
Director
2,434 $0 0
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
2028-05-16
REPLIGEN CORP RGEN Cox John
Director
3,304 $0 0
(Direct)
View
2020-12-08
Conversion
2020-12-10
6:15 pm
N/A
N/A
Sigilon Therapeutics Inc. SGTX Cox John
Director
4,444 $0 4,444
(Indirect)
View
2020-12-08
Conversion
2020-12-10
6:15 pm
N/A
N/A
Sigilon Therapeutics Inc. SGTX Cox John
Director
4,444 $0 0
(Indirect)
View
2021-06-24
Option Award
2021-06-28
07:15 am
N/A
2031-06-23
Sigilon Therapeutics Inc. SGTX Cox John
Director
8,888 $9.97 8,888
(Direct)
View